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Abstract 
Background: Sickle‑cell trait (HbAS) reduces falciparum malaria risk and suppresses parasitaemia. Although several 
candidate mechanisms have been proposed, their epidemiological, clinical and experimental correlates have not 
been adequately explained. To explore the basis for generally lower parasitaemias and delayed malaria episodes in 
children with HbAS, it is hypothesized here that their spleen‑dependent removal of ring‑infected red blood cells 
(RBCs) is more efficient than in children with normal haemoglobin A (HbAA).
Methods: The mechanical splenic retention of Plasmodium falciparum‑infected RBCs from subjects with HbAS or 
HbAA was investigated using two physiologically relevant methods: microsphiltration and ex vivo spleen perfusion. 
P. falciparum‑infected RBCs obtained from in vitro cultures and from patients were used in either normoxic or hypoxic 
conditions. The effect of sickling in ring‑infected HbAS RBCs was also investigated.
Results: When a laboratory‑adapted parasite strain was analysed, ring‑infected HbAA RBCs were retained in micro‑
sphilters at similar or greater levels than ring‑infected HbAS RBCs, under normoxic (retention rate 62.5 vs 43.8 %, 
P < 0.01) and hypoxic (54.0 vs 38.0 %, P = 0.11) conditions. When parasitized RBCs from Malian children were ana‑
lysed, retention of ring‑infected HbAA and HbAS RBCs was similar when tested either directly ex vivo (32.1 vs 28.7 %, 
P = 0.52) or after one re‑invasion in vitro (55.9 vs 43.7 %, P = 0.30). In hypoxia, sickling of uninfected and ring‑infected 
HbAS RBCs (8.6 vs 5.7 %, P = 0.51), and retention of ring‑infected HbAA and HbAS RBCs in microsphilters (72.5 vs 
68.8 %, P = 0.38) and spleens (41.2 vs 30.4 %, P = 0.11), also did not differ. Retention of HbAS and HbAA RBCs infected 
with mature P. falciparum stages was greater than 95 %.
Conclusions: Sickle‑cell trait is not associated with higher retention or sickling of ring‑infected RBCs in experimental 
systems reflecting the mechanical sensing of RBCs by the human spleen. As observed with HbAA RBCs, HbAS RBCs 
infected with mature parasites are completely retained. Because the cytoadherence of HbAS RBCs infected with 
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Background
Despite its deleterious consequences, haemoglobin S 
(HbS, β6 Glu  →  Val) has reached high prevalence in 
malaria-endemic areas [1, 2] due to its natural selection 
by falciparum malaria. HbS exists as a balanced poly-
morphism in sub-Saharan Africa, where it protects chil-
dren with sickle-cell trait (HbAS heterozygotes) from 
falciparum malaria morbidity and mortality but causes 
sickle-cell disease in HbSS homozygotes [3]. While HbAS 
children are protected from severe malaria, uncompli-
cated malaria, and high parasitaemia [4–8] compared 
to HbAA children, the mechanisms that mediate these 
protections remain under active investigation. Although 
several candidate mechanisms have been proposed 
[9–11], their epidemiological, clinical and experimental 
correlates have not been adequately explained. For exam-
ple, Malian HbAS children experience their first malaria 
episode about 1 month later in the transmission season 
compared to HbAA children, despite these two groups of 
children having a comparable parasitaemia at the time of 
their first malaria episode [12].
To explore the basis for generally lower parasitaemias 
and delayed malaria episodes in HbAS children, it is 
hypothesized here that their spleen-dependent removal 
of ring-infected red blood cells (RBCs) is more efficient 
than in HbAA children. Such an effect would achieve 
a lower parasitaemia that would be tolerated without 
symptoms, and delay progression to a higher parasitae-
mia that produces symptoms [13, 14]. A slower rise in 
parasitaemia in HbAS children may conceivably result 
from an enhanced adaptive immune response to P. falci-
parum antigens or from a more effective innate clearance 
of circulating infected RBCs in the spleen, as suggested 
by enhanced phagocytosis of ring-infected HbAS RBCs 
in vitro [15]. While several studies have reported no dif-
ferences between HbAS and HbAA children in the inten-
sity of adaptive immune responses to parasite antigens 
[16–18], others have reported some differences [19].
In exploring a protective role for the spleen, one poten-
tially relevant observation is that HbAS RBCs are less 
deformable than HbAA RBCs, evidenced in part by their 
greater retention in leukocyte-depletion filters [20]. Also, 
P. falciparum ring-infected HbAS RBCs were found to 
sickle faster than uninfected HbAS RBCs when treated 
with reducing agents or exposed to very low O2 concen-
trations [21, 22]. Given these findings, investigators have 
long speculated that the spleen’s preferential destruction 
of sickled, ring-infected HbAS RBCs may protect HbAS 
children from clinical malaria and high parasitaemia. 
Alternatively, since the cytoadherence of HbAS RBCs 
infected with mature parasites is significantly impaired 
[23, 24], the splenic retention and destruction of such 
non-adherent infected RBCs may result in a slower rise 
of P. falciparum parasitaemia in sickle-cell trait carriers. 
Retention of infected RBCs in the spleen may involve 
both biomechanical processes and cell–cell adhesion 
between infected RBCs and splenic structures. However, 
consistent with the absence of detectable parasite pro-
teins on the surface of ring-infected RBCs, their retention 
in isolated-perfused spleens (performed in the absence of 
plasma or antibodies) is biomechanical in nature [25].
Taking advantage of recent progress in studying splenic 
retention in vitro and ex vivo [26], these possibilities were 
investigated using validated tools, such as ektacytometry, 
microsphiltration and human spleen perfusion under 
conditions that induce or do not induce the sickling of 
uninfected and infected HbAS RBCs.
Methods
Blood collection
HbAA and HbAS RBCs were collected in Mali and 
France. In Mali, blood donors were children who par-
ticipated in a cohort study of genetic and acquired pro-
tection from falciparum malaria [5], and were found to 
be healthy and aparasitaemic at the time of blood col-
lection. This study is registered at Clinicaltrials.gov 
(NCT00669084) and was approved by the Institutional 
Review Board (IRB) of the National Institute of Allergy 
and Infectious Diseases, US National Institutes of Health, 
and the Ethics Committee of the Faculty of Medicine, 
Pharmacy and Odontostomatology, University of Bam-
ako. The parents of all children gave written informed 
consent.
In France, HbAS and HbSS RBCs were collected at the 
Necker Hospital from HbAS parents or HbSS children 
who were identified through routine haemoglobinopa-
thy screening and prenatal counselling programmes; in 
all cases, parents provided written informed consent for 
the use of left-over blood samples. HbAA RBCs were col-
lected from healthy donors in parallel. These sample col-
lections were approved by the IRB of Paris VI University. 
The Ile de France VI IRB has approved this approach as a 
non-research process (Article L1121-1, French Code for 
Public Health).
mature parasites is impaired, the very efficient splenic retention of such non‑adherent infected RBCs is expected to 
result in a slower rise of P. falciparum parasitaemia in sickle‑cell trait carriers.
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All venous blood samples were collected in ACD Vacu-
tainers® (Becton–Dickinson, Rungis, France) and washed 
three times with RPMI-1640 (Life Technologies, Saint-
Aubin, France) to remove the buffy coat and plasma. 
RBCs were stored at 4 °C and used within 24 h.
Plasmodium falciparum strains and culture
Trophozoite stages of the P. falciparum laboratory line 
FUP and Malian P. falciparum clinical isolates (prepared 
by collecting ring stages from children with malaria and 
culturing them ex  vivo) were purified using MACS col-
umns (Miltenyi Biotec, San Diego, CA, USA), inoculated 
into fresh HbAA, HbAS and HbSS RBCs in parallel, and 
then studied at the ring stage. In some experiments, para-
sites were allowed to mature for 36 h to the trophozoite 
stage before being used in filtration experiments.
In France, parasites were cultured at 2  % haematocrit 
in RPMI-1640 media containing 25 mM HEPES, 25 mM 
NaHCO3, 0.3  g/L glutamine, 10  mg/L gentamicin (Life 
Technologies) and 10  % human AB+ serum, and incu-
bated at 37 °C in an atmosphere of 21 % O2, 5 % CO2 and 
74 % N2. In Mali, parasites were cultured similarly, except 
that 0.5 % AlbuMAX® II (Life Technologies) was used to 
supplement the media instead of human AB+ serum.
Microsphilter preparation
Calibrated metal microbeads (microspheres) composed 
of 96.5  % tin, 3.0  % silver and 0.5  % copper were used 
to reconstitute very narrow spaces mimicking the inter-
endothelial slit of the human spleen red pulp micro vein 
(sinus). Microspheres were obtained from Industrie des 
Poudres Sphériques (24A, rue de la Résistance-BP 438, 
Annemasse 74108, France). Two different size distribu-
tions (5- to 15-μm diameter and 15- to 25-μm diameter) 
were used throughout. A total of 1 g of dry microspheres 
of each sort was mixed and then suspended in 5 mL of 
phosphate-buffered saline (PBS)/1 % AlbuMAX II (Invit-
rogen). A total of 800 μL of this microsphere suspension 
was poured into an inverted 1000-μL anti-aerosol pipette 
tip (Neptune, BarrierTips) and allowed to settle, lead-
ing to the formation of a 5-mm thick microsphere layer 
above the anti-aerosol filter.
Microsphiltration
A total of 600 µL of RBC suspension (2 % haematocrit in 
PBS/1 % AlbuMAX® II) was instantaneously introduced 
upstream from the microsphere layer. The microsphere 
layer was then washed with 6 mL of PBS/1 % AlbuMAX II 
using an electric pump (Syramed μsp6000, Arcomed’Ag) 
at a flow rate of 60  mL/h. The downstream sample 
(6.6 mL) and an aliquot from the upstream sample were 
analysed. In some experiments, hypoxic conditions were 
created by gassing the RBC suspension and the PBS/1 % 
AlbuMAX® II solution with a gas mixture of 1 % O2, 5 % 
CO2 and 94 % N2 for 15 min and microsphiltration was 
performed in a hermetic plastic tent (Captair Pyramid®; 
Erlab, Val de Reuil, France) that was inflated, deflated 
and re-inflated with the same gas mixture prior to each 
experiment (Additional file  1). Maintenance of 1  % O2 
and 5 % CO2 levels in the RBC suspension was confirmed 
every 15–30  min using an i-STAT® System and CG4+ 
cartridge (Abbott Point of Care, Princeton, NJ, USA). 
The mean parasitaemias (per cent of infected RBCs in the 
RBC suspension) in the upstream (U) and downstream 
(D) samples were determined for duplicate samples. The 
RBC retention rate (RR) for each sample was calculated 
using the following formula: RR = [(U−D)/U] × 100.
Cell counting
Uninfected and ring-infected RBCs were labelled with 
SYTO® 61 red fluorescent nucleic acid stain (Life Tech-
nologies) to detect parasite DNA. Briefly, 100 µL of RBCs 
were incubated in 1 mL of a 1/1000 dilution of SYTO61 
in PBS/2  % AlbuMAX solution for 15  min. The RBCs 
were then washed three times with PBS and PKH26 (red) 
or PKH67 (green) lipophilic fluorescent cell linker probes 
were used to label HbAS and HbAA RBC membranes, 
respectively, according to the manufacturer’s instructions 
(Sigma-Aldrich, Saint-Quentin, France). Cell counting 
was performed using an Accuri C6 flow cytometer (Bec-
ton–Dickinson), and 20,000 events were recorded.
Sickling in stringent hypoxic conditions followed 
by microsphiltration
To investigate the influence of hypoxia-induced sickling 
on the retention of ring-infected RBCs, these cells were 
suspended at 2  % haematocrit in PBS/1  % AlbuMAX® 
II and exposed to a gas mixture containing a lower O2 
concentration (0.5  % O2, 5  % CO2 and 94.5  % N2) sup-
plemented with 2 L of CO2 within a hermetic plastic tent. 
The final concentration of CO2 in the tent was 6.5  %. 
The variation of dissolved CO2 and O2 partial pressures 
was measured using an i-STAT® System and CG4+ car-
tridge (Abbott Point of Care, Princeton, NJ, USA). At 0, 
5, 15, 30 and 45  min after exposure to the gas mixture, 
500-µL samples were fixed in 500 µL of 1 % glutaralde-
hyde for up to 15 min, pelleted and used to prepare a thin 
smear on a glass slide. The slide was then labelled with 
1:1500 Hoechst 33,342 stain (H3570; Molecular Probes, 
Inc, Eugene, OR, USA) in PBS/1  % AlbuMAX® II for 
30  min, washed four times with 1X PBS, and covered 
with VECTASHIELD® anti-fade mounting media for flu-
orescence (Vector Laboratories, Burlingame, CA, USA) 
and a cover slide. Using a fluorescence microscope, RBCs 
were observed under red fluorescence and parasite DNA 
under UV fluorescence. Images were acquired on a Leica 
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DMI3000 microscope, using a Leica DFC310FX camera 
controlled by LAS Superposition Images software (Leica 
Microsystems, Nanterre, France). Uninfected RBCs and 
ring-infected RBCs were separately categorized into three 
groups: discoid RBCs, sickled RBCs, or indeterminate 
RBCs that were neither discoid nor sickled. To validate 
cell counts by microscopy, discoid RBCs, sickled RBCs, 
discoid ring-infected RBCs, and sickled ring-infected 
RBCs were also quantified using imaging flow cytometry 
as previously described [27]. Briefly, glutaraldehyde-fixed 
RBCs were passed through an Image Stream Mark II 
Imaging Flow Cytometer (EMD Millipore, Billerica, MA, 
USA) and 50,000 events acquired using Inspire V4.0 soft-
ware. Post-acquisition data analysis was performed using 
IDEAS V6.2 software. An algorithm that correctly differ-
entiates discoid and sickled RBCs was created. Sickling 
rates were calculated by dividing the number of sickled 
RBCs by all RBCs (i.e., discoid + sickled + indeterminate 
RBCs).
Human spleen retrieval and ex vivo spleen perfusion
Human spleens were retrieved from patients undergo-
ing splenopancreatectomy for pancreatic diseases and 
processed as previously described [28]. Briefly, medical 
and surgical care was not modified, and written informed 
consent was obtained from all patients. The study was 
approved by the Ile-de-France II IRB. The main splenic 
artery was cannulated, and the spleen flushed with 
RPMI-1640 containing 0.3 % Albumax II and 1 µg/L gen-
tamicin (Life Technologies), transferred to the laboratory, 
and connected to the perfusion device. Fresh HbAA and 
HbAS RBCs were inoculated with mature-stage MACS-
purified P. falciparum and incubated for 12–36 h at 37 °C 
in an atmosphere of 21 % O2 and 5 % CO2 until reinva-
sion occurred. The two RBC populations were then 
differentially labelled with two lipophilic fluorescent 
cell-linker probes: PKH26 for HbAA RBCs and PKH67 
for HbAS RBCs. The two labelled RBC suspensions 
were then mixed with fresh RBCs (French Blood Estab-
lishment, Rungis, France) to achieve a 15–25  % haema-
tocrit. The mixture was then perfused into the spleen 
ex vivo using the perfusion device. During perfusion, key 
physiologic markers (TO2, TCO2, glucose, lactate) were 
maintained at physiological levels. Spleen effluents were 
sampled at various time points during perfusion. Fluores-
cence signals of the HbAA RBC and HbAS RBC popu-
lations were detected and the parasitaemia of each RBC 
population determined by flow cytometry as described 
above. The relative retention rates were then calculated 
as described above. Relative retention rate is defined here 
as retention of ring-infected HbAA RBCs in all (infected 
and uninfected) HbAA RBCs from the same culture or 
retention of ring-infected HbAS RBCs in all (infected 
and uninfected) HbAS RBCs from the same culture (see 
Additional files 2, 3). The retention rate at the end of the 
perfusion (at 60 min) was considered the retention rate in 
the spleen.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 
6 software (GraphPad, San Diego, CA, USA). The Mann–
Whitney test, Kruskal–Wallis test, or t test with Welch’s 
correction were used, as appropriate. All P values are 
two-tailed and deemed significant when <0.05.
Results
Retention of Plasmodium falciparum ring‑infected HbAA 
and HbAS RBCs
To mimic the situation occurring in human subjects, the 
relative retention rates of infected HbAA RBCs vs all 
(infected and uninfected) HbAA RBCs, or HbAS RBCs 
vs all (infected and uninfected) HbAS RBCs, were deter-
mined. In experiments using the P. falciparum line FUP, 
the mean retention rate (± SEM) of ring-infected HbAA 
RBCs in microsphilters was higher than that of ring-
infected HbAS RBCs in both normoxic (54.5  % ±  4.7 vs 
44.5  % ±  3.3, P =  0.06; Fig.  1a) and moderately hypoxic 
conditions (54.0 % ± 7.0 vs 38.0 % ± 6.0, P = 0.11; Fig. 1b). 
The mean retention rate of ring-infected HbSS RBCs in 
microsphilters (33.3 % ± 9.1, P = 0.09) was even lower in 
normoxic conditions (Fig. 1a). In experiments using ring-
infected RBCs collected directly from Malian children 
with malaria, the mean retention rates of HbAA and HbAS 
samples were not different (32.1 % ± 2.0 vs 28.7 % ± 4.7, 
P = 0.52; Fig. 1c) (Additional file 5: Table S1). After inva-
sion of P. falciparum clinical isolates into fresh HbAA 
and HbAS RBCs and cultivation to ring stages in  vitro, 
the mean retention rates of HbAA and HbAS sam-
ples were also not significantly different (55.9 % ± 6.0 vs 
43.7 % ± 10.0, P = 0.30; Fig. 1d) (Additional file 5: Table 
S2). When co-perfused through two isolated human 
spleens for 60  min ex  vivo, the retention rates of ring-
infected HbAA and HbAS RBCs were not significantly 
different (37.2 vs 45.2 % in spleen 1, and 27.7 vs 33.1 % in 
spleen 2) (Fig.  3a). These data indicate that ring-infected 
HbAS RBCs are no less filterable than ring-infected 
HbAA RBCs in microsphilters in vitro (even in moderately 
hypoxic conditions) or in human spleens ex vivo.
Hypoxia‑induced sickling of ring‑infected and uninfected 
RBCs
Previous reports had observed the enhanced sickling of 
ring-infected HbAS RBCs compared to uninfected HbAS 
RBCs upon exposure to 8 % sodium metabisulfite, dith-
ionite, or stringent hypoxic conditions (100  % N2) [21, 
22], and speculated that this property would enhance the 
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destruction of sickled ring-infected RBCs in the spleen. 
To investigate whether sickling influences the splenic 
retention of ring-infected RBCs, it was first established 
that exposure to stringent hypoxia (0.5  % O2, 5  % CO2 
and 94.5 % N2 for 45 min) induced sickling in uninfected 
HbAS and HbSS RBCs (Fig.  2a). In experiments using 
uninfected and ring-infected RBCs (see later), sickling 
rates were calculated by enumerating the numbers of dis-
coid, sickled, and indeterminate RBCs (Fig. 2b) and then 
calculating the proportion of all RBCs that was sickled. 
When exposed to stringent hypoxia for 15 min (initiated 
sickling) and 45  min (established sickling), no enhance-
ment of sickling in ring-infected HbAS or HbSS RBCs 
was observed as compared to uninfected ring-infected 
HbAA RBCs. In fact, sickling rates at 45 min were slightly 
lower in ring-infected vs uninfected RBCs: mean ± SEM, 
5.7 % ± 6.0 vs 8.6 % ± 5.7 in HbAS, and 32.7 % ± 12.0 
vs 41.7 % ± 8.6 in HbSS samples (Fig. 2c). Sickling rates 
derived from microscopy or imaging flow cytometry 
were significantly correlated (Pearson r = 0.81, P = 0.001; 
Fig. 2d).
Effect of sickling‑inducing hypoxia on the retention 
of ring‑infected HbAA and HbAS RBCs
To investigate the effects of hypoxia-induced sickling on 
the splenic retention of ring-infected RBCs, P. falciparum 
(FUP line) ring-infected HbAA and HbAS RBCs were 
exposed to stringent hypoxia for various times and then 
passed through microsphilters under the same hypoxic 
condition. This showed that the relative retention rates 
of ring-infected HbAA and HbAS RBCs in micro-
sphilters were similar, but significantly higher than those 
of ring-infected HbSS RBCs, after 15  min of hypoxia: 
mean ± SEM, 74.8 % ± 1.1 for HbAA, 64.6 % ± 8.8 for 
HbAS, and 29.2  %  ±  10.3 for HbSS (Fig.  3b). Similar 
results were found after 45 min of hypoxia: 72.5 % ± 1.5 
for HbAA, 68.8 % ± 4.9 for HbAS, and 46.6 % ± 7.1 for 
HbSS (Fig. 3c).
Fig. 1 Retention of Plasmodium falciparum ring‑infected RBCs. a Mean retention rate (± SEM) of P. falciparum (FUP line) ring‑infected HbAA 
(n = 16), HbAS (n = 26) and HbSS (n = 4) RBCs in microsphilters under normoxic conditions. b Mean retention rate (± SEM) of P. falciparum (FUP 
line) ring‑infected HbAA (n = 4) and HbAS (n = 8) RBCs in microsphilters exposed to ‘moderate’ hypoxia (1 % O2, 3 % CO2, 96 % N2 for 15 min). c 
Median retention rate (interquartile range, range) of ring‑infected RBCs obtained directly from Malian HbAA (n = 29) and HbAS (n = 8) children 
with P. falciparum malaria and passed through microsphilters under normoxic conditions. d Mean retention rates (± SEM) of ring‑infected HbAA 
(n = 6) and HbAS RBCs (n = 6) passed through microsphilters under normoxic conditions. These samples were prepared by obtaining P. falciparum 
isolates from Malian children with malaria, cultivating them to the schizont stage, purifying and inoculating them into fresh HbAA and HbAS RBCs 
simultaneously, and cultivating them to the ring stage in parallel
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Retention of mature Plasmodium falciparum‑infected 
HbAA and HbAS RBCs
HbAA and HbAS RBCs were inoculated with P. falcipa-
rum, cultured in vitro for 36 h until parasites matured to 
the trophozoite stage and filtered. In four independent 
experiments, essentially all of the mature P. falciparum-
infected HbAS and HbAA RBCs were retained in the 
microsphilters (Fig. 3d).
Discussion
This study shows that ring-infected HbAS RBCs displayed 
retention rates that were similar or lower than those of 
ring-infected HbAA RBCs in  vitro (microsphiltration) 
and ex vivo (perfused human spleens). To mimic the situ-
ation occurring in human subjects, experiments were per-
formed with HbAA rings mixed in HbAA RBCs or HbAS 
rings mixed in HbAS RBCs. This finding was unexpected 
given that uninfected HbAS RBCs are less deformable 
than uninfected HbAA RBCs [13, 14] (Additional file 4). 
It was thus conceivable that, after being invaded by P. 
falciparum and subjected to the effects of initial parasite 
development, ring-infected HbAS RBCs would become 
even less deformable than uninfected HbAS RBCs and 
thereby more retained in microsphilters and human 
spleens. Despite this logical assumption, ring-infected 
HbAS RBCs were not more retained than ring-infected 
HbAA RBCs in microsphilters. This observation, which 
was initially made using the P. falciparum FUP strain in 
normoxic conditions, was reproduced in microsphilters 
using the FUP strain in moderately hypoxic conditions 
(1 % O2, 3 % CO2 and 96 % N2) and multiple parasite iso-
lates from Malian children in normoxic conditions either 
before or after in vitro cultivation.
Together, these data suggest that sickle-cell trait does 
not suppress parasitaemia by enhancing the mechani-
cal retention of ring-infected RBCs in the spleen. While 
the retention of ring-infected RBCs was partial in these 
experimental systems that mimic the mechanical sens-
ing of RBCs by the spleen, mechanical retention of HbAS 
RBCs infected with mature parasites was very effective 
and complete, as previously observed with P. falciparum-
infected HbAA RBC [25, 26]. Because the cytoadherence 
Fig. 2 Hypoxia‑induced sickling of uninfected and Plasmodium falciparum (FUP line) ring‑infected RBCs. a Mean sickling rates (± SEM) in unin‑
fected HbAS (n = 5) and HbSS RBCs (n = 3) exposed to ‘stringent’ hypoxia (0.5 % O2, 5 % CO2, 94.5 % N2) (left y-axis), and partial pressures of O2 and 
CO2 (right y-axis) measurements over 45 min. b Morphologies of uninfected RBCs and ring‑infected RBCs (iRBCs) exposed to stringent hypoxia: 
discoid RBC (1), sickled RBC (2), indeterminate RBC (3), discoid iRBC (4), sickled iRBC (5) and indeterminate iRBC (6). c Mean sickling rates (± SEM) of 
uninfected and ring‑infected HbAS and HbSS RBCs exposed to stringent hypoxia for 45 min. RBC morphology was determined by microscopy.  
d Correlation between mean sickling rates obtained using two RBC morphology counting methods, microscopy and imaging flow cytometry.  
The haemoglobin type and infection status of each sample is shown
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of HbAS RBCs infected with mature parasites is impaired 
[23], it is proposed here that the very efficient splenic 
retention of such non-adherent infected RBCs may result 
in a slower rise of P. falciparum parasitaemia in sickle-cell 
trait carriers.
The aforementioned experiments assumed that the 
microsphilter retention of ring-infected RBCs results 
from parasite-induced alterations in the shape or mem-
brane rigidity of ring-infected RBCs [14, 29]. However, 
increased rigidity of ring-infected HbAS RBCs may also 
result from parasite-induced sickling, which increases 
their cytoplasmic viscosity. Previous studies of HbAS 
RBCs ex  vivo [21] and in  vitro [22] reported enhanced 
sickling of ring-infected RBCs as compared to uninfected 
RBCs, and thus speculated that HbAS (but not HbAA) 
children benefitted from enhanced destruction of ring-
infected RBCs in their spleens. To test this possibility, the 
mechanical retention of ring-infected HbAS (and HbSS) 
RBCs was investigated in experimental conditions that 
induced sickling. When exposed to sickling-inducing, 
physiologically-relevant gas mixtures, both uninfected 
and ring-infected HbAS and HbSS RBCs showed no dif-
ferences in their sickling rates. Even under conditions 
that induced high sickling rates, the retention rates of 
ring-infected HbAS and HbAA RBCs were similar. These 
results, which were obtained at O2 and CO2 concentra-
tions observed in the venous effluent of human spleens 
perfused ex  vivo [28] and without reducing agents, dif-
fer strikingly from previous observations [21, 22] and are 
in agreement with pioneering explorations on this topic 
[30]. Together, these data suggest that sickle-cell trait 
does suppress parasitaemia by enhancing the retention of 
sickled, ring-infected RBCs in the spleen.
Overall, these results suggest that the malaria-pro-
tective effects of HbAS do not involve enhanced reten-
tion of ring-infected RBCs in the spleen, and call for a 
re-analysis of proposed mechanisms of protection that 
implicate parasite-induced sickling in clearing ring-
infected HbAS RBCs or impairing parasite develop-
ment in HbAS RBCs [17]. This study shows that mature 
P. falciparum-infected HbAS RBCs are very efficiently 
mechanically retained in the spleen. These findings 
Fig. 3 Retention of hypoxia‑exposed Plasmodium falciparum (FUP line)‑infected RBCs. a Mean retention rates (± SEM) of ring‑infected HbAA 
(n = 2) and HbAS (n = 2) RBCs in two isolated human spleens over 60 min of perfusion ex vivo. b Mean retention rates (± SEM) of ring‑infected 
HbAA (n = 3), HbAS (n = 5) and HbSS (n = 4) RBCs in microsphilters after exposure to ‘stringent’ hypoxia (0.5 % O2, 5 % CO2, 94.5 % N2) for 15 min. 
c Mean retention rates (± SEM) of ring‑infected HbAA (n = 3), HbAS (n = 5) and HbSS (n = 3) RBCs in microsphilters after exposure to stringent 
hypoxia for 45 min. d Mean retention rate (± SEM) of mature P. falciparum‑infected HbAA (n = 4) and HbAS (n = 5) RBCs in microsphilters
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reinforce other candidate mechanisms of malaria pro-
tection, for example, abnormal PfEMP1 display and 
impaired cytoadherence of trophozoite-infected HbAS 
RBCs [23]. By reducing the proportion of mature tropho-
zoite-infected RBCs that is bound to the microvessels of 
vital organs, HbAS may increase the proportion that is 
retained and destroyed in the spleen, thus suppressing 
parasitaemia in the next life cycle and ameliorating the 
symptoms of uncomplicated and severe malaria (Fig. 4). 
This model of malaria protection is supported by previ-
ous findings that HbAS is associated with a 50 % reduc-
tion in the binding of mature trophozoite-infected RBCs 
to microvascular endothelial cells [23] and that mature 
trophozoite-infected RBCs are completely retained in 
microsphilters and isolated perfused human spleens 
[26]. These data are supported by this study’s finding 
that all mature trophozoite-infected HbAS RBCs are 
essentially retained in microsphilters.
Fig. 4 Proposed model for sickle‑cell trait‑related protection from high Plasmodium falciparum parasitaemia and severe malaria. a The preserved 
deformability and normal surface of RBCs enable their efficient navigation through small vessels 1, crossing of narrow inter‑endothelial slits (IES) in 
the wall of red pulp sinuses in the spleen 2, and escape from recognition by red pulp macrophages (MΦ) 3, resulting in rapid exiting from the spleen 
4. b In HbAA patients, mature P. falciparum‑infected RBCs express numerous PfEMP1 adhesins on their surface that mediate their accumulation in 
small vessels through adherence to endothelial cells 1. The few rigid mature forms that escape cytoadherence‑based sequestration in small vessels 
cannot cross IES in the spleen 2, and are ultimately phagocytosed by splenic macrophages 3. While a proportion of RBCs infected with young ring 
forms is mechanically retained upstream from IES 4, most persist in circulation 5. The large population of RBCs infected with mature forms seques‑
tered in small vessels 1 causes direct pathogenic effects leading to severe malaria and rapidly leads to high parasitaemia 6. c In HbAS patients, 
mature P. falciparum‑infected RBCs express few PfEMP1 adhesins on their surface, resulting in a less‑intense accumulation in small vessels 1. Those 
RBCs that escape cytoadherence‑based sequestration in small vessels cannot cross IES in the spleen 2. This retention is expected to result in their 
phagocytosis by splenic macrophages 3. The small population of HbAS RBCs infected with mature forms sequestered in small vessels 1 give rise to 
only a small population of circulating ring‑infected RBCs 6. HbAS patients may be protected from severe malaria by an amelioration of pathogenic 
effects due to a smaller biomass of infected RBCs sequestered in small vessels resulting from mechanical retention of non‑adherent RBCs infected 
with mature forms in the spleen. This mechanism also explains lower parasitaemia and delayed time to a malaria episode
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Conclusions
These observations suggest a very important role of the 
spleen in controlling parasite load in HbAS children by 
the efficient retention and phagocytosis of those mature 
trophozoite-infected RBCs that fail to cytoadhere [15].
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